Refine by
Research Biomark Articles & Analysis
26 news found
“We are excited to provide in vivo models of diabetes mellitus, which represent a significant leap forward in diabetes research,” said the marketing manager of Ace Therapeutics. “These models will allow researchers to explore therapeutic strategies more effectively and ultimately accelerate the development of new treatments that can improve ...
This enhancement aims to offer more precise and comprehensive glycoprotein analysis, catering to the growing demands in the fields of biomedical research, disease biomarker discovery, and therapeutic development. Protein glycosylation, a major post-translational modification, significantly impacts protein folding, stability, and activity. ...
BIOMARK RECEIVES FUNDING SUPPORTING RESEARCH AND DEVELOPMENT PROJECT FOR CANCER TREATMENT MONITORING Vancouver, British Columbia – (February 7th, 2023) – BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF), an advanced stage ...
“In the Cancers paper, investigators, led by CancerCare Manitoba researchers and BioMark collaborators, Drs. Donald W. Miller and Marshall Pitz, describe the activity of LNP-siSAT1 against the GB cells and its ability to further sensitized them towards radiation and chemotherapy providing an avenue to increase treatment efficacy and hence potentially ...
The company’s precision neurology platform is designed to accelerate and improve drug development, research, and care for people with neurological diseases, like Alzheimer’s, using data captured with a standard smartphone or tablet. ...
Among the broad set of more than 50 biomarkers available for translational research are VIDA’s latest measures, offered in clinically oriented tiers. ...
Joint research of biomarkers on platform technology of GI Innovation, GI-SMART™, and SpAC9 Pipeline, AI-powered biomarker discovery platform of CellKey Prediction of drug response on next-generation immuno-oncology, personalized cancer treatment effects… increasing reliability and efficiency of treatment GI Innovation, an ...
Joint research of biomarkers on platform technology of GI Innovation, GI-SMARTTM and SpAC9 Pipeline, AI-powered biomarker discovery platform of CellKey Prediction of drug response on next generation immuno-oncology, personalized cancer treatment effects… increasing Reliability and efficiency of treatment GI Innovation, a new ...
Precision for Medicine, a clinical research organization specializing in advanced therapies, is an early adopter of this new offering and will deploy the Deep Lens solution to assist its sponsors in rapidly identifying the sites and patients best suited for their oncology studies. ...
CD Genomics, a genomics services company, has become one of the top providers in genomic research, devoting to providing reliable services to pharmaceutical and biotech companies as well as academia and government agencies. ...
Creative Proteomics, an integrated CRO company committed to providing a full range of services to support various proteome-related research projects from identification of single proteins to large-scale proteomic studies, has recently upgraded its fully-developed Exosome Proteomics Service to identify and quantify the proteins in exosomes. The company can also help discover ...
.: “We are excited to be bringing this best-in-class product to biopharma and biomarker researchers.” Darlene Murphy, Vice President of Commercial Operations, MOBILion Systems Inc., adds: “In 2017, we set our goal to launch at ASMS 2021 in Philadelphia, even with the pandemic delaying ASMS this year, we remained true to the plan and achieved ...
Creative Biolabs provides label-free proteomics for the discovery of biomarkers, which has overcome the limitation of labeling and quantitative technology in the number of samples and can be implemented in a short experiment period in a flexible and convenient way. ...
As the incidence and mortality of lung cancer rank among the highest all over the world, lung cancer diagnostics and treatment are the most researched paper topics. Research has reported that exosomes derived from lung cancer are the most promising biomarkers for early diagnosis, prognosis, and treatment of lung cancer. With years of experience ...
The grant will support the pre-clinical development of CFTX-1554, Confo’s lead candidate for neuropathic pain, which was initially discovered under a previous VLAIO research grant. Confo is developing CFTX-1554 based on its promise as a potential treatment for patients living with peripheral neuropathic pain, a debilitating condition for which current treatment methods are ...
Thermo Fisher Scientific, the world leader in serving science, today announced new collaborations of the Thermo Fisher Precision Medicine Science Center (PMSC) with AstraZeneca and the University of Nebraska Medical Center as part of its ongoing development of innovative solutions for unmet needs in clinical biomarker discovery. The new alliances strengthen the PMSC's mission of ...
Digital biomarker awards support technology solutions for early detection of Alzheimer’s and related dementias Data platform enables researchers using digital tools to share their findings for benchmarking, analysis and use across research projects ADDF’s Diagnostics Accelerator has $50 million in commitments from leading ...
Whether it’s in administration, accounting or product design & manufacturing, Augurex is committed to quality processes that create a solid foundation for our commercialized products, scientific collaborations and pipeline biomarker development. Schedule your meeting with Augurex today Join Augurex with the global rheumatology community and learn about cutting edge ...
Merck has significant collaborations with leading universities and research institutes to help advance the vaccine industry as a whole, including Baylor College of Medicine and Oxford University’s Jenner Institute. ...
In addition, we will provide examples how the current platform is ideal for biomarker discovery, biotherapeutics research, antibody and aptamer production, protein analysis, and cellular science. ...